U.S. stocks were mixed, with the Dow Jones falling around 200 points on Tuesday.

Shares of Fabrinet (NYSE:FN) rose sharply after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates. Also, the company authorized a repurchase of up to an additional $103 million of its ordinary shares.

Fabrinet reported quarterly earnings of $4.34 per share, which beat the Street estimate of $4.19, per Benzinga Pro data. Quarterly revenue of $1.47 billion beat the consensus estimate of $1.403 billion by 5.11 percent. This is a 50.74 percent increase over sales of $978.128 million the same period last year.

Fabrinet shares jumped 13.7% to $358.08 on Tuesday.

Here are some other big stocks recording gains in today’s session.

• Ibotta Inc (NYSE:IBTA) shares jumped 28.4% to $64.19 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.
• Xtend AI Robotics, Inc (NYSE:XTND) gained 21.4% to $1.59. XTEND AI Robotics completed delivery under $2.8 million Defense contract in Asia-Pacific.
• Aehr Test Systems (NASDAQ:AEHR) rose 19.3% to $61.40 after the company reported better-than-expected first-quarter financial results and raised its FY27 sales guidance above estimates.
• Graphic Packaging Holding Co (NYSE:GPK) gained 19% to $11.10 after the company reported better-than-expected quarterly financial results.
• Sequans Communications SA ADR (NYSE:SQNS) gained 17.8% to $2.98 after the company reported upbeat quarterly financial results.
• EverQuote, Inc. (NASDAQ:EVER) rose 17.6% to $28.83 after the company reported better-than-expected third-quarter sales results and issued current-quarter sales guidance above estimates.
• Bicara Therapeutics Inc. (NASDAQ:BCAX) jumped 17.4% to $9.31.
• BETA Technologies, Inc. (NYSE:BETA) rose 15.2% to $23.50 after the company reported better-than-expected quarterly financial results and raised its FY26 sales guidance above estimates.
• Hut 8 Corp. (NASDAQ:HUT) gained 15.1% to $63.70.
• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) rose 14.8% to $166.96 after the company reported better-than-expected quarterly financial results and raised its FY26 INGREZZA net product sales guidance.
• Sportradar Group AG (NASDAQ:SRAD) climbed 14.7% to $14.77 after the company reported upbeat quarterly financial results.
• Lattice Semiconductor Corporation (NASDAQ:LSCC) gained 14% to $108.83 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates.
• Revvity, Inc. (NYSE:RVTY) gained 12.5% to $170.64 following strong quarterly earnings.
• Fiserv, Inc. (NASDAQ:FISV) surged 12.3% to $58.34 after the company reported better-than-expected quarterly financial results.
• Grab Holdings Limited (NASDAQ:GRAB) rose 10.6% to $3.1650 after the company reported upbeat quarterly sales results and raised its FY26 sales guidance.
• UL Solutions Inc. (NYSE:ULS) gained 9.1% to $81.97 following strong quarterly results.
• Summit Therapeutics Inc. (NASDAQ:SMMT) rose 8.8% to $16.12.
• DuPont de Nemours, Inc. (NYSE:DD) surged 8.8% to $154.27 after the company reported better-than-expected quarterly financial results and raised its FY26 guidance above estimates.
• Bloom Energy Corporation (NYSE:BE) gained 8.6% to $213.14 after the company announced it signed a memorandum of understanding with California Resources Corporation (NYSE:CRC) and its carbon management business, Carbon TerraVault, to jointly evaluate and target the potential development of 1 gigawatt or more of solid-oxide fuel cell power generation paired with carbon capture and storage in California.
• Monolithic Power Systems, Inc. (NASDAQ:MPWR) rose 8.2% to $1,346.17.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.